Seres Therapeutics
MCRB
MCRB
91 hedge funds and large institutions have $916M invested in Seres Therapeutics in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
68% less call options, than puts
Call options by funds: $1.67M | Put options by funds: $5.14M
Holders
91
Holding in Top 10
1
Calls
$1.67M
Puts
$5.14M
Top Buyers
| 1 | +$27.7M | |
| 2 | +$10.7M | |
| 3 | +$7.83M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.68M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.13M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$5.62M | |
| 3 | -$2.53M | |
| 4 |
O
OrbiMed
New York
|
-$2.34M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.41M |